Corona Updates You Must Track: Record Jump In Daily Cases And Deaths, India COVID-19 Tally At 45.62 Lakh
An estimated 64 lakh Indians could have been already exposed to the coronavirus by mid-May, as per the findings of the first national sero-survey. Serum Institute halts trials of experimental vaccine in India
India cases and toll: In yet another record jump in fresh cases and deaths in a day, India reported 96,551 coronavirus cases and 1,209 deaths in the last 24 hours (8 a.m. Thursday to 8 a.m. Friday), as per the data shared by the Ministry of Health and Family Welfare. The country reported 95,735 cases and 1,172 COVID-19 deaths the previous day.
India’s coronavirus tally has now reached 45,62,414 with 9,43,480 active cases and 35,42,663 recoveries. India’s COVID-19 toll has climbed to 76,271, which is the third-highest in the world after the US and Brazil. Meanwhile, India conducted 11,63,542 COVID-19 tests on Thursday.
Delhi records another peak: A day after reporting more than 4,000 cases (4,039) for the first time, Delhi recorded 4,308 cases of coronavirus in the last 24 hours. It also conducted a record 58,340 tests for COVID-19 on Thursday. The national capital’s COVID-19 count rose to 2,05,482, with the toll climbing to 4,666—28 people succumbed to the infection in the last 24 hours. Of the total caseload, 25,416 are active cases while recoveries stand at 1,75,400.
COVID-19 tracker for 11 September. Source: Twitter/@COVIDNewsByMIB
Results of first national sero-survey out: An estimated 6.4 million or 64 lakh people (0.73 per cent of the adult population of India) could have been exposed to the SARS-CoV-2 infection by mid-May 2020, as per the findings of the first national sero-survey conducted by the Indian Council of Medical Research (ICMR). The report, which was published in the Indian Journal of Medical Research, also said that the sero-positivity was the highest in the 18-45 age group. The survey was carried out between 11 May and 4 June among 28,000 individuals.
Serum Institute of India halts trails of vaccine: Pune-based Serum Institute of India on Thursday said it was putting the clinical trials of the experimental COVID-19 vaccine, jointly developed by Oxford University and British-Swedish pharma major AstraZeneca, on hold. The announcement came after the Drugs Controller General of India issued a notice to Serum Institute for not informing it about the suspected adverse effects of the vaccine reported in a patient in the UK and AstraZeneca subsequently halting the global trials of the vaccine.
Health Ministry’s revised SoP for conducting exams: In a bid to check the spread of COVID-19, the Health Ministry on Thursday issued revised guidelines for conducting examinations. Older or pregnant employees or those with underlying medical conditions will not deployed for invigilation. “Frisking of examinees, if needed, shall be undertaken after thermal screening. Personnel involved in frisking shall wear triple layer medical mask in addition to gloves,” the fresh rules state.
Global corona update: The global coronavirus tally has climbed to 2,83,28,080 with 70,71,462 active cases, 2,03,42,700 recoveries and 9,13,918 deaths, as per Worldometer. Of the total infected patients, 60,738 are in serious or critical condition.
The US, with 65,88,163 coronavirus cases and 1,96,328 deaths, is leading the tally. A recent survey in the US has found that public confidence in an early vaccine for coronavirus is declining. The survey, which was conducted by the Kaiser Family Foundation, also found that people’s trust in Centers for Disease Control and Prevention (CDC) has dropped, reported STAT.